The American Journal of Cardiology®
Advanced SearchSave search
Roundtable discussion| Volume 99, ISSUE 2, P213-221, January 15, 2007

The Editor’s Roundtable: Statin Therapy in Acute Coronary Syndrome

Published:November 18, 2006DOI:https://doi.org/10.1016/j.amjcard.2006.10.003
The Editor’s Roundtable: Statin Therapy in Acute Coronary Syndrome
Previous ArticleThe Evolving Pattern of Symptomatic Coronary Artery Disease in the United States and Canada: Baseline Characteristics of the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) Trial
Next ArticleReduction in Predicted Coronary Heart Disease Risk After Substantial Weight Reduction After Bariatric Surgery
      This activity is supported by an educational grant from Pfizer, Inc., New York, New York.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Scandinavian Simvastatin Survival Study Group
        Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S).
        Lancet. 1994; 344: 1383-1389
        View in Article
        • Sacks F.M.
        • Pfeffer M.A.
        • Moye L.A.
        • Rouleau J.L.
        • Rutherford J.D.
        • Cole T.G.
        • Brown L.
        • Warnica W.
        • Arnold J.M.O.
        • Wun C.
        • Davis B.R.
        • Braunwald E.
        • Cholesterol and Recurrent Events Trial Investigators
        The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels.
        N Engl J Med. 1996; 335: 1001-1009
        View in Article
        • The Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) Study Group
        Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels.
        N Engl J Med. 1998; 339: 1349-1357
        View in Article
        • Arntz H.R.
        • Agrawal R.
        • Wunderlich W.
        • Schnitzer L.
        • Stern R.
        • Fischer F.
        • Schultheiss H.P.
        Beneficial effects of pravastatin (+/−cholestyramine/niacin) initiated immediately after a coronary event (the randomized Lipid-Coronary Artery Disease [L-CAD] Study).
        Am J Cardiol. 2000; 86: 1293-1298
        View in Article
        • Cannon C.P.
        • Braunwald E.
        • McCabe C.H.
        • Rader D.J.
        • Rouleau J.L.
        • Belder R.
        • Joyal S.V.
        • Hill K.A.
        • Pfeffer M.A.
        • Skene A.M.
        Intensive versus moderate lipid lowering with statins after acute coronary syndromes.
        N Engl J Med. 2004; 350: 1495-1504
        View in Article
        • de Lemos J.A.
        • Blazing M.A.
        • Wiviott S.D.
        • Lewis E.F.
        • Fox K.A.
        • White H.D.
        • Rouleau J.L.
        • Pedersen T.R.
        • Gardner L.H.
        • Mukherjee R.
        • Ramsey K.E.
        • Palmisano J.
        • Bilheimer D.W.
        • Pfeffer M.A.
        • Califf R.M.
        • Braunwald E.
        Early intensive vs. a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial.
        JAMA. 2004; 292: 1307-1316
        View in Article
        • Dupuis J.
        • Tardif J.C.
        • Cernacek P.
        • Theroux P.
        Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes.
        Circulation. 1999; 99: 3227-3233
        View in Article
        • Kayikcioglu M.
        • Can L.
        • Evrengul H.
        • Payzin S.
        • Kultursay H.
        The effect of statin therapy on ventricular late potentials in acute myocardial infarction.
        Int J Cardiol. 2003; 90: 63-72
        View in Article
        • Kinlay S.
        • Schwartz G.G.
        • Olsson A.G.
        • Rifai N.
        • Leslie S.J.
        • Sasiela W.J.
        • Szarek M.
        • Libby P.
        • Ganz P.
        High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study.
        Circulation. 2003; 108: 1560-1566
        View in Article
        • Pedersen T.R.
        • Jahnsen K.E.
        • Vatn S.
        • Semb A.G.
        • Kontny F.
        • Zalmai A.
        • Nerdrum T.
        Benefits of early lipid-lowering intervention in high-risk patients: the lipid intervention strategies for coronary patients study.
        Clin Ther. 2000; 22: 949-960
        View in Article
        • Schwartz G.G.
        • Olsson A.G.
        • Ezekowitz M.D.
        • Ganz P.
        • Oliver M.F.
        • Waters D.
        • Zeiher A.
        • Chaitman B.R.
        • Leslie S.
        • Stern T.
        Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial.
        JAMA. 2001; 285: 1711-1718
        View in Article
        • Waters D.D.
        • Schwartz G.G.
        • Olsson A.G.
        • Zeiher A.
        • Oliver M.F.
        • Ganz P.
        • Ezekowitz M.
        • Chaitman B.R.
        • Leslie S.J.
        • Stern T.
        Effects of atorvastatin on stroke in patients with unstable angina or non–Q-wave myocardial infarction: a Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) substudy.
        Circulation. 2002; 106: 1690-1695
        View in Article

      Article Info

      Publication History

      Published online: November 18, 2006
      Accepted: October 4, 2006
      Received: October 4, 2006

      Footnotes

      The manuscript is based on a meeting of the authors on March 21, 2006.

      Identification

      DOI: https://doi.org/10.1016/j.amjcard.2006.10.003

      Copyright

      © 2007 Elsevier Inc. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2022 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX